This inventor holds 57 USPTO granted patents and 15 published patent applications, plus 4 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Technology (CPC class C07D). Top assignees: Nikon Corporation, Chugai Seiyaku Kabushiki Kaisha, Sony Corporation. Active years: 1987-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Ebina, JP (1987)
- Yokohama, JP (1992)
- Kawaskai, JP (1996)
- Chiba, JP (2000)
- Tokyo, JP (1987 - 2001)
- Kanagawa-ken, JP (1998 - 2009)
- Kawasaki, JP (1990 - 2011)
- Kanagawa, JP (1996 - 2023)
- Kamakura, JP (2024)
Company Filing History:
34 out of 8,997 
7 out of 987 
5 out of 58,147 
Years Active: 1987-2024
Areas of Expertise:
Title: Innovations of Hiroshi Sakamoto: Pioneering Cancer Treatments
Introduction
Hiroshi Sakamoto, located in Kawasaki, Japan, is a distinguished inventor and researcher with an impressive portfolio of 57 patents. His contributions primarily focus on novel drug compounds aimed at treating cancer, showcasing his dedication to advancing medical science and improving patient outcomes.
Latest Patents
Among his latest innovations is a combination drug designed for the treatment and prevention of cancer. This groundbreaking invention merges an ALK inhibitor with a VEGF inhibitor, demonstrating significant efficacy in combatting cancer and inhibiting tumor growth. Additionally, he has developed a RET inhibitor, a compound capable of being utilized in preventing and treating various disorders, including cancers with mutations in the RET gene. This invention represents a significant step forward in oncology, offering new hope to patients facing challenging diagnoses.
Career Highlights
Hiroshi Sakamoto has made substantial contributions to the field of pharmaceuticals throughout his career. He has been affiliated with prestigious organizations, including Nikon Corporation and Chugai Seiyaku Kabushiki Kaisha, where he has leveraged his expertise to innovate and develop life-saving treatments. His work reflects not only his ingenuity but also a commitment to addressing critical health challenges.
Collaborations
Throughout his career, Sakamoto has collaborated with notable professionals in the field, including Nobuyoshi Hagiuda and Hideki Matsui. These partnerships have likely enriched his research and contributed to the successful development of his innovative compounds, underscoring the importance of collaboration in scientific discovery.
Conclusion
Hiroshi Sakamoto stands as a prominent figure in the world of innovation and invention within the pharmaceutical industry. His extensive patent portfolio and dedication to cancer treatment underscore the pivotal role that inventors play in advancing healthcare. As research continues to evolve, Sakamoto's contributions will undoubtedly impact the future of cancer treatment and inspire further innovations in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile